Paul M. Harari
University of Wisconsin–Madison(US)University of Wisconsin Carbone Cancer Center(US)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Radiopharmaceutical Chemistry and Applications, Advanced Radiotherapy Techniques, HER2/EGFR in Cancer Research
Most-Cited Works
- → Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck(2006)5,079 cited
- → Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival(2009)1,965 cited
- → Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial(2018)1,262 cited
- Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.(1999)
- → Understanding resistance to EGFR inhibitors—impact on future treatment strategies(2010)688 cited
- Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.(2000)
- →